Laboratory Corporation of America Holdings http://www.alacrastore.com/company-snapshot/Laboratory_Corporation_of_America_Holdings-1055466 Sunday, October 12, 2008 5:12:50 AM 1055466 Laboratory Corporation of America Holdings en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/BW-0001-28479170newstex/BW-0001-28479170xml Oct. #, #### (Business Wire) -- Laboratory Corporation of AmericaA® Holdings (LabCorpA®) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Optiona„¢ Notes due #### (LYONs) and Zero Coupon Convertible Subordinated...04000000040020000400200610/1/2008 8:22:57 AM18000000180040001900000019001000Business WireBW-0001-28479170LABORATORY CORP OF AMERICA HOLDINGSLHNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/673981spcred/673981normThe latest Summary from S&Pglobal9/29/2008 11:33:17 PM175Summary673981United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe rating on Burlington, N. C.-based Laboratory Corp. of America Holdings (LabCorp) reflects the company's position as one of only two national independents in the clinical laboratory services market, as well as its broad, industry-leading specialty-testing capabilities and history of strong cash flow generation. The ratings also take into account the company's narrow business focus and its dependence on a favorable reimbursement environment. During the past decade, the diagnostic testing industry experienced a period of rapid consolidation, driven, in part, by pricing pressure from third-party payors. LabCorp has cemented its No. 2 position through a series of acquisitions and contract wins. The acquisitions have expanded the company's national presence, improved its economies of scale, and increased its higher margin specialtyUSA50540R50540S50540Q35102015 351020 3510 35Laboratory Corp. of America Holdings314930USALHSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T1978088ccbn/T1978088norm... - Laboratory Corporation - IRGood morning, everyone, and welcome again to the #### UBS global life sciences conference. My name is [Cece Zhang], and it is my pleasure to introduce to you our next two speakers. We have Dave King, President and CEO and Brad Hayes, Chief Financial Officer of Laboratory Corporation of America. Following the discussion there will be a breakout in the Broadway room downstairs. Thank you. ... 9/23/2008 1:05:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at UBS Global Life Sciences Conference TranscriptLH11:00am ETTranscriptT1978088Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1945919ccbn/T1945919norm... - - AnalystAs you are aware we're required to make a number of conflict of interest and related disclosures in connection with our participation in this conference and the Company's that we may discuss. If you'd like to review these important disclosures please pick up the packets containing the public appearance disclosures at the back of this room, PDF copies can be accessed by those of you viewing the presentation by the Webcast. We're very pleased to have Laboratory Corp of America here to present today. We do see an expanding value proposition in laboratory services that we don't think is fully reflected in the stock as yet. Here to speak to the opportunity are Dave King who is the Chief Executive Officer. He's joined by Brad Hayes, the Chief Financial Officer and Eric Lindblom , Director of Investor Relations.... 9/17/2008 5:05:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Bank of America Securities Annual Investment Conference TranscriptLH10:00am PTTranscriptT1945919Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1915944ccbn/T1915944norm... - Banc of America Securities - AnalystYou are aware that we are required to make a number of conflict of interest and related disclosures in connection with our participation in this conference and the companies that we may discuss. If you would like to review these important disclosures, please pick up the packets containing the public appearance disclosures at the back of this room. PDF copies can be accessed by those of you viewing these presentations via the webcast. Well good morning. I'm Robert Willoughby. I'm the rogue healthcare services analyst here at the Specialty Pharmaceutical Conference this year. Very pleased to have LabCorp of America join us today at the conference. I've basically been sitting in on a number of these presentations and I've struggled to really see how you manage the risk of a failed drug. I do like the diagnostic play much better for the steady revenue and profit growth that we've consistently seen for the Street. We've asked Andy Conrad to give us some... 8/8/2008 3:06:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Bank of America Securities Specialty Pharmaceuticals Conference TranscriptLH10:15am ETTranscriptT1915944Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1877697ccbn/B1877697norm...Excluding consolidation of Ontario, Canada JV, revenue increased #.#%, with volume increasing #.#% and price increasing #.#%. ... 7/24/2008 10:14:00 PMLaboratory Corporation of America54.0000EditedLaboratory Corporation of America Q2 2008 Earnings Conference Call SummaryLH9:00am ETBriefB1877697Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1877697ccbn/T1877697norm...Good day, ladies and gentlemen. Welcome to the second quarter #### Laboratory Corporation of America's earnings conference call. I will be your coordinator today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of this call. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to the host for the call, Mr. David King, President and CEO. Please proceed. ... 7/24/2008 11:04:00 AMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America Q2 2008 Earnings Conference Call TranscriptLH9:00am ETTranscriptT1877697Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1882446ccbn/T1882446norm... - Wachovia Securities - AnalystHello, I'm the healthcare analyst for Wachovia. Thank you all very much for being here on this beautiful morning. I am super excited to introduce Dave King, who is the CEO of LabCorp. LabCorp is a stock that we're recommending right now. It's been one of our favorite names over time. Dave is one of our favorite CEOs. I think most of you are pretty familiar with the story. He's probably going to do a slightly abbreviated presentation and leave a lot of time open for the questions you have about what might be going on in the business right now. With that I'll introduce Dave King, CEO of LabCorp. ... 6/25/2008 3:04:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Wachovia Nantucket Equity Conference TranscriptLH8:00am ETTranscriptT1882446Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1880569ccbn/T1880569norm... - Jefferies & Co. - AnalystOkay, good morning. For those of you that don't know me, I'm Arthur Henderson, I'm the healthcare services analyst here at Jeffries. Thank you, guys, for coming. Our next speaker I'm very excited about is Laboratory Corporation of America. Most of you know, these guys are one of the largest providers of laboratory services in the United States. With us today is Dave King, President and CEO; and then we have Brad Smith here, EVP of Corporate Affairs. And Dave, without further ado, thank you for coming.... 6/24/2008 10:16:00 AMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Jefferies & Co. Annual Healthcare Conference TranscriptLH8:30am ETTranscriptT1880569Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1876681ccbn/T1876681norm... - William Blair - AnalystOkay, we'll go ahead and get started. Good morning. My name is Amanda Murphy, and I cover LabCorp here at William Blair. This is the first time that LabCorp has been at our conference, so we're very happy to have them here today. We have CEO David King, CFO Brad Hayes, and Senior VP of Investor Relations Eric Lindblom. As many of you know, LabCorp is the second-largest clinical lab in the United States and operates in what we believe to be a very attractive space. In our view, lab testing is becoming an increasingly important component of improving healthcare outcomes, as well as driving cost savings for payors. And we believe LabCorp is uniquely positioned in this market, given its strategy to provide value-added services to payors, as well as expanding lab testing beyond diagnostics into wellness prevention and disease testing and monitoring, which hopefully Dave will talk about. Before I turn it over, a couple of administrative points. First, I'm required... 6/17/2008 4:04:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at William Blair & Company Growth Stock Conference TranscriptLH10:30am CTTranscriptT1876681Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1873467ccbn/T1873467norm... - Goldman Sachs - AnalystThank you, and welcome to the LabCorp presentation. On behalf of Matt Borst and myself, we are very pleased to introduce the management of LabCorp, who are attending our conference for the first time this year. And we have David King and Brad Smith on stage with us today to present some slides, and then they'll open it up for Q&A. ... 6/11/2008 4:05:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Goldman Sachs Healthcare Conference TranscriptLH8:40am PTTranscriptT1873467Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1847400ccbn/T1847400norm... - Banc of America Securities - AnalystAs you are aware, we are required to make a number of conflict of interest and related disclosures in connection with our participation in the conference and the companies that we may discuss. If you would like to review these important disclosures, please pickup the packets containing the public affairs disclosures at the back of this room. PDF copies can be accessed by those of who are reviewing these presentations via the webcast. I thank you all for coming. Lab Corp is one of our top four long recommendations in pharma services this year and (inaudible) Willoughby favorite. It is executing a fairly straight forward strategy that assures an above industry average growth rate for the forceable future. Here to hit the high points are Dave King, who is Chief Executive Officer. He is joined on the podium by Brad Hayes, the Chief Financial Officer and in audience, we do have Eric Lindblom, Direct of Investor Relations. ... 5/14/2008 6:06:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Bank of America Securities Health Care Conference TranscriptLH9:20am PTTranscriptT1847400Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1806694ccbn/B1806694norm...Management discussed #Q## results, reporting diluted EPS of $#.## on net sales of $#.####b. Guidance was for #### diluted EPS of $#.##-#.## (diluted) on revenue growth of ##-##.#%. www.streetevents.comContact Us ... 4/24/2008 12:11:00 PMLaboratory Corporation of America54.0000EditedQ1 2008 Laboratory Corporation of America Earnings Conference Call SummaryLH9:00am ETBriefB1806694Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1806694ccbn/T1806694norm...Good day, ladies and gentlemen, and welcome to the Laboratory Corporation of America press call of #### earnings conference call. My name is Sylvanna and I'll be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's conference, Mr. David King, Chief Executive Officer. You may proceed, sir. ... 4/24/2008 12:11:00 PMLaboratory Corporation of America54.0000FinalQ1 2008 Laboratory Corporation of America Earnings Conference Call TranscriptLH9:00am ETTranscriptT1806694Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/spcred/640349spcred/640349normThe latest Full Report from S&P4/1/2008 1:19:36 PMFull Report400global640349United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareFull ReportPosition as one of only two national independents in the clinical laboratory services market; Broad, industry-leading specialty-testing capabilities; and History of strong cash flow generation. Narrow business focus; and Dependence on a favorable reimbursement environment. The rating on Burlington, N. C.-based Laboratory Corp. of America Holdings (LabCorp) reflects the company's position as one of only two national independents in the clinical laboratory services market, as well as its broad, industry-leading specialty-testing capabilities and history of strong cash flow generation. The ratings also take into account the company's narrow business focus and its dependence on a favorable reimbursement environment. During the past decade, the diagnostic testing industry experienced a period of rapid consolidation, driven, in part, by pricing pressure from third-partyUSA50540R50540S50540Q35102015 351020 3510 35Laboratory Corp. of America Holdings314930USALHFULLGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/640350spcred/640350normThe latest Summary from S&P4/1/2008 1:19:36 PMSummary175global640350United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe rating on Burlington, N. C.-based Laboratory Corp. of America Holdings (LabCorp) reflects the company's position as one of only two national independents in the clinical laboratory services market, as well as its broad, industry-leading specialty-testing capabilities and history of strong cash flow generation. The ratings also take into account the company's narrow business focus and its dependence on a favorable reimbursement environment. During the past decade, the diagnostic testing industry experienced a period of rapid consolidation, driven, in part, by pricing pressure from third-party payors. LabCorp has cemented its No. 2 position through a series of acquisitions and contract wins. The acquisitions have expanded the company's national presence, improved its economies of scale, and increased its higher margin specialtyUSA50540R50540S50540Q35102015 351020 3510 35Laboratory Corp. of America Holdings314930USALHSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T1796881ccbn/T1796881norm...It's a great pleasure to have with us LabCorp. LabCorp is one of the nation's leading clinical laboratory companies. From the Company today, we have Dave King, the Company's CEO, Brad Hayes, the Company's CFO, and Eric Lindblom, the Company's Director of IR. It's a great pleasure to have the Company join us today. This is a real focus (inaudible) for us over the past several years, and the Company has been very -- its strategy and it has a lot of exciting growth opportunities in the future. So with that, let me turn it over to Dave King. ... 3/19/2008 8:05:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Lehman Brothers Healthcare Conference TranscriptLH10:45am ETTranscriptT1796881Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1779945ccbn/T1779945norm... - Cowen and Company - Analyst, Moderator We'll go ahead and get started. Like to wish everyone a good afternoon and a welcome. I'm Kemp Dolliver of Cowen and Company, the Healthcare Services Analyst who covers LabCorp, and I'd like to thank you all for joining us today, both those of you in the room and those on the webcast, and we're pleased to have LabCorp's senior management here speaking with us today.There are three representatives from the Company. First, there will be -- is David King, CEO; Brad Smith, Executive Vice President for Corporate Affairs; and Eric Lindblom, who is Vice President for Investor Relations and Public Affairs. The Company will make a presentation. If there's some time left, we'll do some Q&A in the room here, and then after that, we will adjourn for the breakout session, which is in the Province Town Room, which is up on the fourth floor, I should point out. So for those in your room who want to go to the breakout session, you'll need to go up the escalators.... 3/18/2008 8:05:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at Cowen and Company Health Care Conference TranscriptLH1:40pm ETTranscriptT1779945Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1760636ccbn/T1760636normLaboratory Corporation of America at UBS Global Healthcare Services Conference2/11/2008 2:07:00 PMLaboratory Corporation of America54.0000FinalLaboratory Corporation of America at UBS Global Healthcare Services Conference TranscriptLH10:30am ETTranscriptT1760636Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1735469ccbn/B1735469normQ# #### Laboratory Corporation of America Earnings Conference Call2/7/2008 3:08:00 PMLaboratory Corporation of America54.0000EditedQ4 2007 Laboratory Corporation of America Earnings Conference Call SummaryLH9:00am ETBriefB1735469Credit & Investment ResearchThomson StreetEvents